A POINT OF CARE DIAGNOSTIC DEVICE FOR MONITORING CD4 LEVELS IN HIV PATIENTS IN A RESOURCE POOR SETTING Group 14: Lina Aboulmouna Peter DelNero Parker Gould.

Slides:



Advertisements
Similar presentations
Endothelial Progenitor Cell (EPC) Core Laboratory Instructions Version 5.0 March 29, 2008 For questions regarding collection, processing, storage, or shipping.
Advertisements

Dr. Thaweesak Tirawatnapong Chula Medical Research Center (Chula MRC)
C. parvum polyclonal antibodies (Abcam Inc., Cambridge, MA) are adsorbed to the surface of the gold nanoparticles. To create stable conjugates, the surface.
Thermography Adam Adgar School of Computing and Technology.
King Saud University Riyadh Saudi Arabia Dr. Gihan Gawish Assistant Professor 1.
Pilot Implementation of Point-Of-Care CD4 Counting in Mozambique’s National Health System Ilesh V. Jani Instituto Nacional de Saúde Maputo, Mozambique.
Western Analysis Laboratory procedure that allows you to:
Reactive Oxygen Species (ROS) Mitochondrion and ROS Electron Transport Chain: Complexes I-V.
July 2008 Jonathan Sommer.  Has two modes to view samples Optical mode (white light) and Fluorescence mode  Depending on your sample either mode maybe.
Intro to Lab-on-a-Chip
Drug Delivery & Tissue Engineering Laboratory
Circulating Tumor Cells
R. Hui Photonics for bio-imaging and bio- sensing Rongqing Hui Dept. Electrical Engineering & Computer Science, The University of Kansas, Lawrence Kansas.
Cell Separation Using Magnetic Beads
Design of Health Technologies lecture 12 John Canny 10/17/05.
Monolithic Microfabricated Valves and Pumps by Multilayer Soft Lithography EECE 491C Unger et al. (Quake group, CALTECH) Science, 2000.
Micro-Fluidic Device for Antigen Discovery
Integrated Circuits Design for Applications in Communications Dr. Charles Surya Department of Electronic and Information Engineering DE636  6220
Blood Separation in Microfluidic Devices Group #5 Eric Chung Scott Darby Casey Reynolds Jeff Turner.
(Enzyme Linked Immunosorbent Assay)
Antigen antibody reactions
Methods to Detect Red Cell Membrane Disorders
Ilesh V. Jani, MD PhD Instituto Nacional de Saúde Maputo, Mozambique.
DNA ISOLATION. INTRODUCTION  DNA isolation is an extraction process of DNA from various sources. The scientist must be able to separate the DNA from.
Practical Blood Bank Lab 4 Weak D testing (Du).
Emily Salmon Norman Purvis, PhD, Esoterix Development, Simulation and Optimization of Oncology Laboratory Sample Processing Automation.
WHAT IS A WESTERN BLOT?.
Flow cell design for WGM optical biosensor Yongqiang Yang BE8280 spring 2015.
Enzyme Linked Immunosorbent Assay (ELISA). ELISA Enzyme Linked Immunosorbent Assay (ELISA) Term Was Coined By Engvall and Pearlmann in 1971 Different.
Microarray - Leukemia vs. normal GeneChip System.
Lab 4 Practical Blood Bank. Weak expression of the R h D antigen (D u ) The term D U is widely used to describe cells which have :  a quantitative reduction.
NucleoCounter YC-100 Presentation
Bodiflo LLC 1 BODIFLO LLC BodiFLO System. Bodiflo LLC 2 BodiFLO Background Injuries to the head and traumatic brain injury (TBI) make up a substantial.
Absolute CD4+CD25+CD127low/- T Cells (Treg) in Peoples with HIV/AIDS
Antibody Array Assay Report 1. Protocol 2 Protein Extraction 1.Wash the cells with ice cold 1X PBS. 2.Add Lysis Beads and Extraction Buffer to the sample.
Fluorescence microscopy Principle and applications.
Automated Microfluidic Cell Separator Project Group:
Diagnosing patients at point of care
Practical Blood Bank Lab 4 Weak D testing (Du).
Automated Maze System Development Group 9 Tanvir Haque Sidd Murthy Samar Shah Advisors: Dr. Herbert Y. Meltzer, Psychiatry Dr. Paul King, Biomedical Engineering.
Automated Microfluidic Cell Separator
W EAK D T ESTING (D U ) Mr. Mohammed Jaber.. WEAK EXPRESSION OF THE R H D ANTIGEN (D U ) The term D U is widely used to describe cells which have a quantitative.
Instrumented NanoPhysiometer for High Throughput Drug Screening D. Michael Ackermann, Jon Payne, Hilary Samples, James Wells.
Optimization of T-Cell Trapping in a Microfluidic Device Group #19
Automated Microfluidic Cell Separator Project Group:
Development of Microfluidic Glucose Sensors BME 273: Kristen Jevsevar, Jason McGill, Sean Mercado, Rebecca Tarrant Advisors: Jennifer Merritt, Dr. John.
Tracking and Probing Single, Diffusing Molecules in Droplets Mark Arsenault, Peker Milas, Ben Gamari, Richard Buckman, Lori Goldner Biophysics Group MiniSymposium.
TECHNETIUM (99mTc) MACROSALB INJECTION Definition Technetium (99mTc) macrosalb injection is a sterile, a pyrogenic suspension of human albumin in the form.
Lab-on-a-Chip The Ideal Technology for Bio-chemical Analysis
PRESENTATION CSE 341 MICROPROCESSOR Presented By Nabid Kaisar
Cross-matching as part of Pre transfusion compatibility
Multiplex analysis of cytokines Russell Garland KWS BioTest
Immunochromatography
Flowcytometry.
Enzyme-Linked Immunosorbent Assay ELISA
Determination of Hematocrit value (H)
A non-amplification molecular probe approach John Gerdes, Ph. D.
Immunochromatography
Andrew Botelho Jorge Raul Martinez Perez-Tejada Praveer Nidamaluri
Coombs test practical(3)
3-Valve Pumping Sequence 4-Valve Pumping Sequence
Practical Blood Bank Lab 4 Weak D testing (Du).
TECHNETIUM (99mTc) MACROSALB INJECTION
Immunoassay 28/02/2019.
Adsorption Mr. Mohammed A. jaber.
Enzyme Linked  Immuno sorbent  Assay  
Fig. 1 Digital microfluidic cartridge and ELISA used for measles and rubella testing. Digital microfluidic cartridge and ELISA used for measles and rubella.
Practical Blood Bank Lab 4 Weak D testing (Du).
Development, Simulation and Optimization of Oncology Laboratory Sample Processing Automation Emily Salmon Advisor: Norman Purvis, PhD, Esoterix.
Presentation transcript:

A POINT OF CARE DIAGNOSTIC DEVICE FOR MONITORING CD4 LEVELS IN HIV PATIENTS IN A RESOURCE POOR SETTING Group 14: Lina Aboulmouna Peter DelNero Parker Gould Rosie Korman Chris Madison Stephen Schumacher Advisor: Dr. Kevin Seale, BME Vanderbilt University VIIBRE/SyBBURE Nashville, TN

P ROBLEM S TATEMENT The Gates Foundation has identified low-cost HIV testing as a primary global health goal (“Grand Challenges in Global Health”). Current HIV testing methods are slow and expensive Flow cytometers are not suitable for the point-of-care needs for developing countries ~$30,000-$150,000 per flow cytometer. Limitations include energy scarcity, untrained technicians, high capital-cost equipment, patient proximity, low throughput and long feedback period

W HAT IS A CD4+ L YMPHOCYTE ? Note: Image not to scale White blood cell CD4 CD4 Antigen Other surface markers

CD4+ COUNTS AND S TAGE OF HIV I NFECTION Patients with HIV who have CD4+ counts above 500cells/uL are in stage 1, CD4+ counts between 500cells/uL and 200cells/uL are in stage 2, and CD4+ counts of 200cells/uL and below are in stage 3 and are classified as having AIDS. CD4+ countStagePatient’s status >500 cells/uLStage 1HIV-infected cells/uLStage 2HIV-infected <200cells/uLStage 3AIDS

P ERFORMANCE C RITERIA Prototype accurately determines CD4 count Meets $2/test Gates Foundation challenge Small sample volume (single finger-stick) Generate results in minutes Disposable and portable Minimal energy requirements Low technical expertise

P RIMARY OBJECTIVE Create a working prototype that accomplishes the specified goals and meets the performance criteria

D IAGNOSTIC D EVICE D ESIGN Input Outputs PDMS Glass Buffer Antibodies Blood Mixer Pump Filter Device

A NTIBODY CONJUGATION PROTOCOL 1. Suspend antibodies and CMEUs (carboxylate- modified Europium nanoparticles) at 30 ug IgG/mg CMEU in the coating buffer: 10mM NaPO4 pH Allow the antibodies to coat the CMEUs for 1-2 hours, with gentle shaking. 3. After the coating, spin down the CMEUs, remove supernatant, and resuspend in blocking buffer: either 10 mg/ml BSA in buffer, or 5% PEG in buffer 4. Wash 2 or 3 times: Spin down the CMEUs at 10, g, remove supernatant, resuspend in blocking buffer 5. Spin down CMEUs, remove supernatant, resuspend in Conjugate Dilution Buffer

CD4 DETECTION Note: Image not to scale White blood cell CD4 Eu NP ɑ -CD4 Antibody conjugated to Eu nanoparticle Other surface markers Well

1.Stepper Motor 2.Alignment Screws 3.Set Screw 4.Shaft Coupler 5.Fluid Tubing 6.PDMS Washer 7.Thrust Bearing 8.PDMS Device 9.Polycarbonate Base P ERISTALTIC P UMP ( HAND - CRANKABLE ) 3. 5.

P ERISTALTIC P UMP ( HAND - CRANKABLE ) 1.Stepper Motor 2.Alignment Screws 3.Set Screw Thrust Bearing 8.PDMS Device 9.Polycarbonate Base 4.Shaft Coupler 5.Fluid Tubing 6.PDMS Washer

Tunable pore size to selectively trap CD4+ cells F ILTER A RRAY White blood cell Red blood cell Silicon Pore

Tunable pore size to selectively trap CD4+ cells F ILTER A RRAY White blood cell Red blood cell Silicon Pore

Tunable pore size to selectively trap CD4+ cells F ILTER A RRAY White blood cell Red blood cell Silicon Pore

Tunable pore size to selectively trap CD4+ cells F ILTER A RRAY White blood cell Red blood cell Silicon Pore

Tunable pore size to selectively trap CD4+ cells F ILTER A RRAY White blood cell Red blood cell Silicon Pore

Tunable pore size to selectively trap CD4+ cells F ILTER A RRAY White blood cell Red blood cell Silicon Pore

Tunable pore size to selectively trap CD4+ cells F ILTER A RRAY White blood cell Red blood cell Silicon Pore

Input Outputs PDMS Filter Glass Filter with PDMS/Glass coverings

TRF (T IME -R ESOLVED F LUORESCENCE ) I MAGING In a nutshell: Precisely timing a xenon excitation flash and image capture with long lifetime fluorophores (europium nanoparticles). Reduces the impact of background fluorescence.

TRF IMAGING WITH A CELL TRAP DEVICE Possibly CD4+ cells, possibly EuNP aggregates EuNP aggregate and water droplet

G OALS Convert DC pump to hand-cranked mechanical power generator mechanism Integrate microfluidic platform with camera and pumps Separation of white and red cells in whole blood sample Fluorescent conjugation, labeling, and excitation of anti-CD4 antibodies Digital image acquisition Digital image analysis Accomplish the primary objective